Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov;102(11):2380-6.
doi: 10.1111/j.1572-0241.2007.01419.x. Epub 2007 Jul 19.

Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus

Affiliations

Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus

Ganapathy A Prasad et al. Am J Gastroenterol. 2007 Nov.

Abstract

Objectives: Although EMR has been used for elimination of neoplasia in BE, the significance of positive carcinoma margins and depth of invasion on endoscopic resection pathology has not been assessed using a valid standard. The aim of this study was to assess the accuracy of tumor staging by EMR using esophagectomy as the standard.

Methods: Medical records of patients, who underwent endoscopic resection for esophageal carcinoma or high-grade dysplasia in BE followed by esophagectomy, were reviewed. Data were abstracted from a prospectively maintained EMR database. Endosonography and endoscopic resection were performed by a single experienced endoscopist. Two experienced GI pathologists interpreted all histological results. Standard statistical tests were used to compare continuous and categorical variables.

Results: Twenty-five patients were included in the study. Three patients had mucosal carcinoma and 16 had submucosal carcinoma following endoscopic resection. Surgical pathology staging was consistent with preoperative EMR staging in all patients. No patient with negative mucosal resection margins had residual tumor at the resection site at esophagectomy. In patients with submucosal carcinoma, 8 had residual carcinoma at the EMR site at surgery and 5 patients had metastatic lymphadenopathy.

Conclusions: Tumor staging using EMR pathology is accurate when compared with surgical pathology following esophagectomy. Negative margins on EMR pathology correlate with absence of residual disease at the EMR site at esophagectomy. Submucosal carcinoma on EMR specimens was associated with a high prevalence of residual disease at surgery (50%) and metastatic lymphadenopathy (31%).

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

Guarantor of the article: Kenneth K. Wang, M.D.

Specific author contributions: G. A. Prasad: Manuscript preparation and revision, data extraction, statistical analysis; K. K. Wang: Concept, manuscript revision, guarantor, primary endoscopist, senior and corresponding author; N. S. Buttar: Manuscript revision, clinical care of patients; L. M. Wongkeesong: Manuscript revision, clinical care of patients; J. T. Lewis: Interpreration of pathology specimens; S. O. Sanderson: Interpretation of pathology specimens; L. S. Lutzke: Data extraction, clinical care of patients; L. S. Borkenhagen: Clinical care of patients, data extraction.

Figures

Figure 1
Figure 1
Intramucosal adenocarinoma confined by muscularis mucosae. There is a lymphoid aggregate at the lower right corner of the field. No invasion into submucosa is present.
Figure 2
Figure 2
Negative margin showing gastric cardio-oxyntic mucosa. No specialized Barrett mucosa is present.
Figure 3
Figure 3
High grade dysplasia at a lateral mucosal margin. While there is significant atypia present within these glands, there is no effacement of the lamina propria or significant gland fusion to qualify as carcinoma.
Figure 4
Figure 4
Deep margin involved by carcinoma. There are malignant glands and single cells present within mucin pools which are present along the deep margin of the specimen.

References

    1. Prasad GA, Wang KK, Lutzke LS, et al. Frozen section analysis of esophageal endoscopic mucosal resection specimens in the real-time management of Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:173–8. - PMC - PubMed
    1. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation. Hum Pathol. 2001;32:368–78. - PubMed
    1. Pacifico RJ, Wang KK, Wongkeesong LM, et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. [see comment] Clin Gastroenterol Hepatol. 2003;1:252–7. - PubMed
    1. Shimizu Y, Tsukagoshi H, Fujita M, et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–90. - PubMed
    1. Buttar NS, Wang KK, Lutzke LS, et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastroin-test Endosc. 2001;54:682–8. - PubMed

Publication types